A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Hormones signal through two fundamentally different mechanisms based on their chemical nature and membrane permeability. Lipid-soluble hormones (steroid hormones such as cortisol and sex steroids, plus thyroid hormones) diffuse through the plasma membrane and bind to intracellular receptors that act as transcription factors, altering gene expression over hours. Water-soluble hormones (peptides, proteins, and catecholamines) cannot cross the membrane and bind surface receptors, triggering second-messenger cascades (cAMP via adenylyl cyclase; IP3/DAG via phospholipase C) that activate protein kinases within seconds to minutes. Receptor downregulation (decreased receptor number in response to chronically high hormone levels) and upregulation modulate target tissue sensitivity.
Compare cortisol (lipid-soluble: membrane-permeable → nuclear receptor → transcription factor → new protein synthesis in hours) vs. epinephrine (water-soluble: surface GPCR → Gs → adenylyl cyclase → cAMP → PKA → phosphorylation of existing enzymes in seconds). For each, trace the complete path from hormone in blood to final cellular change. Ask: why can a steroid change which proteins a cell makes while a peptide generally modulates existing proteins?
You know from cell signaling that cells respond to chemical messages through receptor binding, and from endocrinology that hormones are long-distance messengers carried in the blood. The question that links these two areas is: *how* does a hormone actually change what a cell does? The answer depends entirely on one structural property — whether or not the hormone can cross the plasma membrane.
Lipid-soluble hormones — steroid hormones like cortisol, testosterone, and estradiol, plus thyroid hormones — diffuse directly through the phospholipid bilayer. Once inside, they bind to intracellular receptors, typically in the cytoplasm or nucleus. The hormone-receptor complex acts as a transcription factor: it binds specific DNA sequences called hormone response elements and turns genes on or off. The result is that the cell manufactures different proteins — a powerful, long-lasting reprogramming of cell behavior. The trade-off is speed: transcription, translation, and protein accumulation take hours.
Water-soluble hormones — peptides like insulin and glucagon, proteins like growth hormone, and catecholamines like epinephrine — cannot cross the membrane at all. They bind surface receptors, most commonly G-protein-coupled receptors (GPCRs). A Gs-coupled GPCR activates adenylyl cyclase, which produces the second messenger cAMP; a Gq-coupled GPCR activates phospholipase C, producing IP3 and DAG. These second messengers activate protein kinases (PKA, PKC), which phosphorylate enzymes that are already present in the cell, switching their activity on or off. This whole cascade unfolds in seconds to minutes — no new protein synthesis required.
The functional contrast is worth sitting with. Epinephrine triggers a muscle cell to mobilize glucose stores in seconds during exercise — that requires speed, and phosphorylating an existing enzyme achieves it. Cortisol suppresses inflammation by altering which immune proteins a cell expresses — that requires sustained changes, and gene regulation achieves it. The signaling mechanism matches the physiological timescale of the response.
Receptor regulation adds an important layer of complexity. When hormone levels are chronically elevated — whether from disease, stress, or exogenous administration — target cells reduce the number of surface or intracellular receptors through downregulation. The cell becomes less responsive, which is why type 2 diabetes involves insulin resistance even with high circulating insulin, and why athletes using anabolic steroids can experience diminished endogenous testosterone responsiveness. Upregulation is the mirror image: chronically low hormone levels can increase receptor density, sensitizing a tissue to even small amounts of hormone.